Vaccine

Messenger RNA
Biotech

Arcturus doubles down on mRNA, axes several early-stage assets

Analysts said the discontinued programs—mRNA vaccines for chlamydia, gonorrhea and Lyme disease—had “low [return on investment] visibility.”
Ben Adams , Gabrielle Masson May 13, 2025 1:32pm
Space shuttle takes off on background of blue sky

Manufacturer Emergent invests in next-gen vax biotech

Mar 12, 2025 10:22am
packing boxes moving layoffs failure shut down

GSK to move vaccine R&D group from Maryland to Massachusetts

Feb 12, 2025 11:27am
Squirting gel onto hand from container

Harmless skin bacteria engineered to be living topical vaccine

Dec 11, 2024 11:00am
computer generated 3D illustration of a clostridium difficile bacterium

mRNA vaccine protects mice from deadly C. diff infections

Oct 4, 2024 1:08pm
concept of computer chip and dollar sign

Merck bags options on Evaxion's AI-designed vaccine candidates

Sep 26, 2024 7:30am